|
Exhibit 1.1
Execution
Version
Burlington Northern Santa
Fe Corporation
UNDERWRITING
AGREEMENT
March 11,
2008
Banc of America Securities
LLC
Barclays Capital Inc.
Wachovia Capital Markets, LLC
As Representatives of the
several
Underwriters named in
Schedule I hereto
Ladies and Gentlemen:
Burlington Northern Santa Fe
Corporation, a Delaware corporation (the “Company”),
proposes, subject to the terms and conditions stated herein (the
“Underwriting Agreement”), between the Company on the
one hand and you, as Representatives of the several underwriters
named in Schedule I hereto (the “Underwriters”), on the
other hand, to issue and sell to the Underwriters the Securities
specified in Schedule II hereto (the “Securities”). All
provisions contained in the document entitled Burlington Northern
Santa Fe Corporation Underwriting Agreement Standard Provisions
(Debt Securities), a copy of which is attached hereto (the
“Standard Provisions”), are hereby incorporated by
reference in their entirety and shall be deemed to be a part of
this Agreement to the same extent as if such provisions had been
set forth in full herein. Unless otherwise defined herein, terms
defined in the Standard Provisions are used herein as therein
defined.
The Issuer Free Writing
Prospectuses referred to in Section 6(a) of the Standard
Provisions are set forth on Schedule III hereto, and any additional
documents incorporated by reference referred to in
Section 2(d) of the Standard Provisions are set forth on
Schedule III hereto. The forms of final term sheets referred to in
Section 5(a) of the Standard Provisions are attached hereto as
Schedule IV. Each reference to the Representatives herein and in
the Standard Provisions shall be deemed to refer to you. The
Representatives are to act on behalf of each of the Underwriters of
the Securities.
Subject to the terms and
conditions set forth herein and in the Standard Provisions, the
Company agrees to issue and sell to each of the Underwriters, and
each of the Underwriters agrees, severally and not jointly, to
purchase from the Company, at the “Time of Delivery”
(as specified in Schedule II hereto) and at the purchase price to
the Underwriters set forth in Schedule II hereto, the principal
amount of Securities set forth opposite the name of such
Underwriter in Schedule I hereto.
1
For the purposes of this
Agreement, the following information is the only information
furnished to the Company by any Underwriter for use in the Basic
Prospectus, any Preliminary Prospectus, any Issuer Free Writing
Prospectus or the Prospectus:
| |
a. |
The second paragraph of text under the caption
“Underwriting” in the Prospectus Supplement, concerning
the terms of the offering by the Underwriters; |
| |
b. |
The second sentence of the third paragraph of text under the
caption “Underwriting” in the Prospectus Supplement,
concerning market making by the Underwriters; and |
| |
c. |
The fourth, fifth and sixth paragraphs of text under the
caption “Underwriting” in the Prospectus Supplement,
concerning stabilization and short positions created by the
Underwriters. |
If the foregoing is in
accordance with your understanding, please sign and return to us
seven counterparts hereof, and upon the acceptance hereof by you,
on behalf of each of the Underwriters, this letter and such
acceptance hereof shall constitute a binding agreement between each
of the Underwriters and the Company. It is understood that your
acceptance of this letter on behalf of each of the Underwriters is
pursuant to the authority set forth in a form of Agreement among
Underwriters, the form of which shall be submitted to the Company
for examination upon request, but without warranty on your part as
to the authority of the signers thereof.
|
|
|
| Very truly yours, |
|
| BURLINGTON NORTHERN SANTA FE CORPORATION |
|
|
| By: |
|
/s/ Julie Piggott |
| Name: |
|
Julie Piggott |
| Title: |
|
VP Finance |
2
|
|
|
| Accepted as of the date hereof: |
|
| BANC OF AMERICA SECURITIES LLC |
|
|
| By: |
|
/s/ Peter J.
Carbone |
| Name: |
|
Peter J. Carbone |
| Title: |
|
Vice President |
|
| BARCLAYS CAPITAL INC. |
|
|
| By: |
|
/s/ Pamela
Kendall |
| Name: |
|
Pamela Kendall |
| Title: |
|
Director |
|
| WACHOVIA CAPITAL MARKETS, LLC |
|
|
| By: |
|
/s/ Scott A.
Brinner |
| Name: |
|
Scott A. Brinner |
| Title: |
|
Vice President |
On behalf of itself and each
of the other Underwriters
3
Schedule I
|
|
|
|
|
Underwriters
|
|
Principal Amount of
Notes
to be Purchased |
|
Banc of America Securities
LLC
|
|
$ |
162,500,000 |
|
Barclays Capital Inc.
|
|
$ |
162,500,000 |
|
Wachovia Capital Markets, LLC
|
|
$ |
162,500,000 |
|
BMO Capital Markets Corp.
|
|
$ |
27,084,000 |
|
BNP Paribas Securities Corp.
|
|
$ |
27,084,000 |
|
BNY Capital Markets, Inc.
|
|
$ |
27,083,000 |
|
Mitsubishi UFJ Securities International
plc
|
|
$ |
27,083,000 |
|
SG Americas Securities, LLC
|
|
$ |
27,083,000 |
|
The Williams Capital Group,
L.P.
|
|
$ |
27,083,000 |
|
|
|
|
|
Total
|
|
$ |
650,000,000 |
ScheduleI-1
Schedule II
5.75% Notes due
March 15, 2018
Title of Securities:
5.75% Notes due
March 15, 2018 (the “Notes”)
Aggregate Principal Amount:
$650,000,000
Price to Public:
99.767% of the principal
amount, plus accrued interest, if any, from March 14,
2008
Purchase Price by
Underwriters:
99.117% of the principal
amount, plus accrued interest, if any, from March 14,
2008
Specified Funds for Payment of Purchase
Price:
By wire transfer to a bank
account specified by the Company in immediately available
funds
Indenture:
Indenture, dated as of
December 1, 1995, between the Company and The Bank of New York
Trust Company, N.A., as successor in interest to J.P. Morgan Trust
Company, National Association, as successor in interest to The
First National Bank of Chicago, as Trustee (the
“Trustee”), as supplemented by the Second Supplemental
Indenture, to be dated as of March 14, 2008, between the
Company and the Trustee
Maturity: March 15, 2018
Interest Rate: 5.75% per
annum
Interest Payment Dates:
March 15 and
September 15, commencing on September 15, 2008
Redemption Provisions:
Redeemable as a whole or in
part, at the option of the Company, at any time, at a redemption
price equal to the greater of (i) 100% of the principal amount
of the Notes and (ii) the sum of the present values of the
remaining scheduled payments of principal and interest on the Notes
discounted to the redemption date semiannually (assuming a 360-day
year consisting of twelve 30-day months) at the Treasury Rate (as
defined below) plus 35 basis points, plus in either case any
accrued and unpaid interest on the Notes to the date of redemption.
The Independent Investment Banker (as defined below) will calculate
the redemption price.
Schedule II-1
“Treasury Rate”
means, with respect to any redemption date, the rate per annum
equal to the semiannual equivalent yield to maturity of the
Comparable Treasury Issue, assuming a price for the Comparable
Treasury Issue (expressed as a percentage of its principal amount)
equal to the Comparable Treasury Price for such redemption
date.
“Comparable Treasury
Issue” means the United States Treasury security selected by
the Independent Investment Banker as having a maturity comparable
to the remaining term of the Notes that would be used, at the time
of selection and in accordance with customary financial practice,
in pricing new issues of corporate debt securities of comparable
maturity with the remaining term of the Notes.
“Independent Investment
Banker” means one of the Reference Treasury Dealers appointed
by the Trustee after consultation with the Company.
“Comparable Treasury
Price” means, with respect to any redemption date,
(i) the average of the bid and asked prices for the Comparable
Treasury Issue (expressed in each case as a percentage of its
principal amount) on the third business day preceding such
redemption date, as set forth in the daily statistical release (or
any successor release) published by the Federal Reserve Bank of New
York and designated “Composite 3:30 p.m. Quotations for U.S.
Government Securities” or (ii) if such release (or any
successor release) is not published or does not contain such prices
on such business day, (A) the average of the Reference
Treasury Dealer Quotations for such redemption date, after
excluding the highest and lowest such Reference Treasury Dealer
Quotations, or (B) if the Trustee obtains fewer than four such
Reference Treasury Dealer Quotations, the average of all such
quotations.
“Reference Treasury
Dealer Quotations” means, with respect to each Reference
Treasury Dealer and any redemption date, the average, as determined
by the Trustee, of the bid and asked prices for the Comparable
Treasury Issue (expressed in each case as a percentage of its
principal amount) quoted in writing to the Trustee by such
Reference Treasury Dealer at 5:00 p.m. on the third business day
preceding such redemption date.
“Reference Treasury
Dealer” means each of Banc of America Securities LLC and
Barclays Capital Inc. and their respective successors; provided,
however, that if any of the foregoing shall cease to be a primary
U.S. Government securities dealer in New York City (a
“Primary Treasury Dealer”), the Company shall replace
that former dealer with another Primary Treasury Dealer.
The Company will mail notice
of any redemption between 30 days and 60 days before the redemption
date to each holder of the Notes to be redeemed.
Unless the Company defaults
in payment of the redemption price, on and after the redemption
date interest will cease to accrue on the Notes or portions of the
Notes called for redemption.
Change of Control Provisions:
If a Change of Control
Repurchase Event occurs, unless the Company has exercised its right
to redeem the Notes as described above, the Company will be
required to make an offer to each holder of Notes to repurchase all
or any part (in integral multiples of $1,000) of that
holder’s Notes at a repurchase price in cash equal to 101% of
the aggregate principal amount of Notes repurchased plus any
accrued and unpaid interest on the Notes repurchased to, but not
including, the date of repurchase. Within 30 days following a
Change of Control Repurchase Event or, at the Company’s
option, prior to a Change of Control, but after the public
announcement of the Change of Control, the Company will mail a
notice to each holder of Notes, with a copy to the Trustee,
describing the transaction or transactions that constitute or may
constitute the Change of Control Repurchase Event and offering to
repurchase Notes on the payment date specified in the notice, which
date will be no earlier than 30 days and no later than 60 days from
the date such notice is mailed. The notice shall, if mailed prior
to the date of consummation of the Change of Control, state that
the offer to purchase is conditioned on a Change of Control
Repurchase Event occurring on or prior to the payment date
specified in the notice. The Company will comply with the
requirements of Rule 14e-1 under the Exchange Act, and any other
securities laws and regulations thereunder to the extent those laws
and regulations are applicable in connection with the repurchase of
the Notes as a result of a Change of Control Repurchase Event. To
the extent that the provisions of any securities laws or
regulations conflict with the Change of Control Repurchase Event
provisions of the Notes, the Company will comply with the
applicable securities laws and regulations and will not be deemed
to have breached its obligations under the Change of Control
Repurchase Event provisions of the Notes by virtue of such
conflict.
On the repurchase date
following a Change of Control Repurchase Event, the Company will,
to the extent lawful:
(1) accept for payment all
Notes or portions of Notes properly tendered pursuant to its
offer;
(2) deposit with the Trustee
an amount equal to the aggregate purchase price in respect of all
Notes or portions of Notes properly tendered; and
(3) deliver or cause to be
delivered to the Trustee the Notes properly accepted, together with
an officers’ certificate stating the aggregate principal
amount of Notes being purchased by the Company.
The Trustee will promptly
mail to each holder of Notes properly tendered the purchase price
for the Notes, and the Trustee will promptly cause to be
transferred by book-entry to each holder a new Note equal in
principal amount to any unpurchased portion of any Notes
surrendered; provided that each new Note will be in a principal
amount of a minimum denomination of $2,000 and an integral multiple
of $1,000.
The Company will not be
required to make an offer to repurchase the Notes upon a Change of
Control Repurchase Event if a third party makes such an offer in
the manner, at the times and otherwise in compliance with the
requirements for an offer made by the Company and such third party
purchases all Notes properly tendered and not withdrawn under its
offer.
For purposes of the foregoing
discussion of a repurchase at the option of holders, the following
definitions are applicable:
“Below Investment Grade
Ratings Event” means that on any day within the 60-day period
(which period shall be extended so long as the rating of the Notes
is under publicly announced consideration for a possible downgrade
by any of the Rating Agencies) after the earlier of (1) the
occurrence of a Change of Control; or (2) public notice of the
occurrence of a Change of Control or the intention by the Company
to effect a Change of Control, the Notes are rated below Investment
Grade by each of the Rating Agencies. Notwithstanding the
foregoing, a Below Investment Grade Ratings Event otherwise arising
by virtue of a particular reduction in rating shall not be deemed
to have occurred in respect of a particular Change of Control (and
thus shall not be deemed a Below Investment Grade Ratings Event for
purposes of the definition of Change of Control Repurchase Event
hereunder) if the Rating Agencies making the reduction in rating to
which this definition would otherwise apply do not announce or
publicly confirm or inform the Trustee in writing that the
reduction was the result, in whole or in part, of any event or
circumstance comprised of or arising as a result of, or in respect
of, the applicable Change of Control (whether or not the applicable
Change of Control shall have occurred at the time of the ratings
event).
“Change of
Control” means the consummation of any transaction
(including, without limitation, any merger or consolidation) the
result of which is that any “person” or
“group” (as those terms are used in
Section 13(d)(3) of the Exchange Act), other than the Company,
its subsidiaries, or its or such subsidiaries’ employee
benefit plans, becomes the beneficial owner (as defined in Rules
13d-3 and 13d-5 under the Exchange Act), directly or indirectly, of
more than 50% of the combined voting power of the Company’s
Voting Stock or other Voting Stock into which the Company’s
Voting Stock is reclassified, consolidated, exchanged or changed
measured by voting power rather than number of shares.
“Change of Control
Repurchase Event” means the occurrence of both a Change of
Control and a Below Investment Grade Ratings Event.
“Investment
Grade” means a rating of Baa3 or better by Moody’s (or
its equivalent under any successor rating category of
Moody’s); a rating of BBB- or better by S&P (or its
equivalent under any successor rating category of S&P); and the
equivalent investment grade credit rating from any additional
Rating Agency or Rating Agencies selected by the
Company.
“Moody’s”
means Moody’s Investors Service, Inc.
“Rating Agency”
means (1) each of Moody’s and S&P; and (2) if
either of Moody’s or S&P ceases to rate the Notes or
fails to make a rating of the Notes publicly available for reasons
outside of the Company’s control, a “nationally
recognized statistical rating organization” within the
meaning of Rule 15c3-1(c)(2)(vi)(F) under the Exchange Act,
selected by the Company (as certified by a resolution of the
Company’s board of directors) as a replacement agency for
Moody’s or S&P, or both of them, as the case may
be.
“S&P” means
Standard & Poor’s Ratings Services, a division of
McGraw-Hill, Inc.
“Voting Stock” of any
specified “person” (as that term is used in
Section 13(d)(3) of the Exchange Act) as of any date means the
capital stock of such person that is at the time entitled to vote
generally in the election of the board of directors of such
person.
Sinking Fund Provisions:
No sinking fund
provisions
Defeasance Provisions:
Legal defeasance and covenant
defeasance permitted upon compliance with conditions set forth in
the Indenture
Time of Sale:
2:36 P.M., Eastern Standard
Time, on March 11, 2008
Time of Delivery:
9:00 A.M., Eastern Standard
Time, on March 14, 2008
Closing Location:
Sullivan & Cromwell
LLP, 125 Broad Street, New York, New York, 10004
Names and Addresses of
Representatives:
Designated
Representatives:
Banc of America Securities
LLC
Barclays Capital
Inc.
Wachovia Capital Markets,
LLC
Address for Notices,
etc.:
c/o Banc of America
Securities LLC
40 West 57th
Street
NY1-040-27-03
New York, NY 10019
Attn: High Grade Transaction
Management / Legal
c/o Barclays Capital
Inc.
200 Park Avenue
New York, NY 10166
c/o Wachovia Capital Markets,
LLC
301 S. College
Street
Charlotte, NC
28202
Schedule III
Materials in Addition to the Pricing
Prospectus comprising the Disclosure Package:
Term Sheet, dated
March 11, 2008
Other Free Writing
Prospectuses:
None
Documents Incorporated by
Reference:
None
Schedule III-1
Schedule IV
Term Sheet
Filed Pursuant to Rule
433
Registration
No. 333-130214
March 11,
2008
Burlington Northern Santa
Fe Corporation
5.75% Notes due
March 15, 2018
|
|
|
|
|
|
Issuer:
|
|
Burlington Northern Santa Fe Corporation |
|
|
|
Note Type:
|
|
Senior
Unsecured Notes |
|
|
|
Ratings:
|
|
Baa1/BBB |
|
|
|
Offering Format:
|
|
SEC
Registered |
|
|
|
Final Terms
|
|
|
|
|
|
Principal Amount:
|
|
$650,000,000 |
|
|
|
Benchmark:
|
|
UST 3.50%
due February 2018 |
|
|
|
Benchmark Yield:
|
|
3.581% |
|
|
|
Re-offer Spread:
|
|
T + 220
bps |
|
|
|
Re-offer Yield:
|
|
5.781% |
|
|
|
Coupon:
|
|
5.750% |
|
|
|
Price to Public:
|
|
99.767% |
|
|
|
Coupon Dates:
|
|
March 15
and September 15 |
|
|
|
First Coupon Date:
|
|
September
15, 2008 |
|
|
|
Trade Date:
|
|
March 11,
2008 |
|
|
|
Settlement Date:
|
|
March 14,
2008 |
|
|
|
Maturity Date:
|
|
March 15,
2018 |
|
|
|
Make Whole Call:
|
|
T + 35
bps |
|
|
|
Day Count Convention:
|
|
30/360 |
Schedule IV-1
|
|
|
|
|
|
Denomination:
|
|
$2,000 x
$1,000 |
|
|
|
CUSIP:
|
|
12189T
BA1 |
|
|
|
Bookrunners:
|
|
Banc of
America Securities LLC, Barclays Capital Inc. and Wachovia Capital
Markets, LLC |
|
|
|
Co-Managers:
|
|
BMO
Capital Markets Corp., BNP Paribas Securities Corp., BNY Capital
Markets, Inc., Mitsubishi UFJ Securities International plc, SG
Americas Securities, LLC, and The Williams Capital Group,
L.P. |
The issuer has filed a registration
statement (including a prospectus) with the SEC for the offering to
which this communication relates. Before you invest, you should
read the prospectus in that registration statement and other
documents the issuer has filed with the SEC for more complete
information about the issuer and this offering. You may get these
documents for free by visiting EDGAR on the SEC Web site at
www.sec.gov. Alternatively, the issuer, any underwriter or any
dealer participating in the offering will arrange to send you the
prospectus if you request it by calling toll-free to Banc of
America Securities LLC at 1-800-294-1322, Barclays Capital Inc. at
1-888-227-2275, Ext. 2663, and Wachovia Capital Markets, LLC at
1-800-326-5897.
Schedule IV-2
Burlington Northern Santa
Fe Corporation
Underwriting
Agreement
Standard
Provisions
(Debt
Securities)
From time to time Burlington
Northern Santa Fe Corporation, a Delaware corporation (the
“Company”), may enter into one or more underwriting
agreements that provide for the sale of debt securities (the
“Securities”) to the several underwriters named
therein. The standard provisions set forth herein may be
incorporated by reference in any such underwriting agreement (an
“Underwriting Agreement”). The Underwriting Agreement,
including the provisions incorporated therein by reference, is
herein referred to as “this Agreement.” Terms defined
in the Underwriting Agreement are used herein as therein
defined.
The terms and rights of any
particular issuance of Securities shall be as specified in this
Agreement and in or pursuant to the indenture (the
“Indenture”) identified in this Agreement.
1. Particular sales of
Securities may be made from time to time to the Underwriters of
such Securities, for whom the firms as representatives of the
Underwriters of such Securities in the Underwriting Agreement
relating thereto will act as representatives (the
“Representatives”). The term
“Representatives” also refers to a single firm acting
as sole representative of the Underwriters and to Underwriters who
act without any firm being designated as their representative. The
obligations of the Underwriters under this Agreement shall be
several and not joint.
2. The Company represents and
warrants to, and agrees with, each of the Underwriters
that:
(a) An “automatic shelf
registration statement” as defined under Rule 405 under the
Securities Act of 1933, as amended (the “Securities
Act”), on Form S-3 (File No. 333-130214) in respect of
the Securities has been filed with the Securities and Exchange
Commission (the “Commission”) not earlier than three
years prior to the date hereof; such registration statement, and
any post-effective amendment thereto, became effective on filing;
and no stop order suspending the effectiveness of such registration
statement or any part thereof has been issued and no proceeding for
that purpose has been initiated or threatened by the Commission,
and no notice of objection of the Commission to the use of such
registration statement or any post-effective amendment thereto
pursuant to Rule 401(g)(2) under the Securities Act has been
received by the Company (the base prospectus filed as part of such
registration statement, in the form in which it has most recently
been filed with the Commission on or prior to the date of this
Agreement, is hereinafter called the “Basic
Prospectus”; any preliminary prospectus, including any
preliminary prospectus supplement, relating to the Securities filed
with the Commission pursuant to Rule 424(b) under the Securities
Act is hereinafter called a “Preliminary Prospectus”;
the various parts of such registration statement, including all
exhibits thereto but excluding Form T-1 and including any
prospectus supplement relating to the Securities that is filed with
the Commission and deemed by virtue of Rule 430B to be part of such
registration statement, each as amended at the time such part of
the registration statement became effective, are
hereinafter
1
collectively called the
“Registration Statement”; the Basic Prospectus, as
amended and supplemented immediately prior to the Time of Sale (as
defined in Section 2(c) hereof), is hereinafter called the
“Pricing Prospectus”; the form of the final prospectus
relating to the Securities filed with the Commission pursuant to
Rule 424(b) under the Securities Act in accordance with
Section 5(a) hereof is hereinafter called the
“Prospectus”; any reference herein to the Basic
Prospectus, the Pricing Prospectus, any Preliminary Prospectus or
the Prospectus shall be deemed to refer to and include the
documents incorporated by reference therein pursuant to
Item 12 of Form S-3 under the Securities Act, as of the date
of such prospectus; any reference to any amendment or supplement to
the Basic Prospectus, any Preliminary Prospectus or the Prospectus
shall be deemed to refer to and include any post-effective
amendment to the Registration Statement, any prospectus supplement
relating to the Securities filed with the Commission pursuant to
Rule 424(b) under the Securities Act and any documents filed under
the Securities Exchange Act of 1934, as amended (the
“Exchange Act”), and incorporated therein, in each case
after the date of the Basic Prospectus, such Preliminary
Prospectus, or the Prospectus, as the case may be; any reference to
any amendment to the Registration Statement shall be deemed to
refer to and include any annual report of the Company filed
pursuant to Section 13(a) or 15(d) of the Exchange Act after
the effective date of the Registration Statement that is
incorporated by reference in the Registration Statement; and any
“issuer free writing prospectus” as defined in Rule 433
under the Securities Act relating to the Securities and identified
as such on Schedule III to the Underwriting Agreement is
hereinafter called an “Issuer Free Writing
Prospectus”);
(b) The Company was a
“well-known seasoned issuer” as defined in Rule 405
under the Securities Act (A) at the time of filing the
Registration Statement, (B) at the time of the most recent
amendment thereto for the purpose of complying with
Section 10(a)(3) of the Securities Act (whether such amendment
was by post-effective amendment, incorporated report filed pursuant
to Section 13 or 15(d) of the Exchange Act or form of
prospectus filed pursuant to the Securities Act), and (C) at
the time the Company or any person acting on its behalf (within the
meaning, for this clause only, of Rule 163(c) under the Securities
Act) made any offer relating to the Securities in reliance on the
exemption of Rule 163 under the Securities Act; and the Company was
not an “ineligible issuer” as defined in Rule 405 under
the Securities Act at the earliest time after the filing of the
Registration Statement that the Company or another offering
participant made a bona fide offer (within the meaning of Rule
164(h)(2) under the Securities Act) of the Securities;
(c) For the purposes of this
Agreement, the “Time of Sale” will be the date and time
of day specified in Schedule II to the Underwriting Agreement; the
Pricing Prospectus as supplemented by those Issuer Free Writing
Prospectuses and other documents so specified in Schedule III to
the Underwriting Agreement and by the final term sheet in the form
attached to the Underwriting Agreement as Schedule IV, prepared and
filed pursuant to Section 5(a) hereof, taken together
(collectively, the “Disclosure Package”) as of the Time
of Sale, did not include any untrue statement of a material fact or
omit to state any material fact necessary in order to make the
statements therein, in the light of the circumstances under which
they were made, not misleading; provided , however ,
that this representation and warranty shall not apply to statements
or omissions made in the Disclosure Package in reliance upon and in
conformity with information furnished in writing to the Company by
an Underwriter through the Representatives
2
expressly for use therein;
and each Issuer Free Writing Prospectus does not conflict with the
information contained in the Registration Statement, the Pricing
Prospectus or the Prospectus;
(d) The documents
incorporated by reference in the Pricing Prospectus and the
Prospectus, when they became effective or were filed with the
Commission, as the case may be, conformed in all material respects
to the requirements of the Securities Act or the Exchange Act, as
applicable, and the rules and regulations of the Commission
thereunder, and none of such documents contained an untrue
statement of a material fact or omitted to state a material fact
required to be stated therein or necessary to make the statements
therein not misleading; and any further documents so filed and
incorporated by reference in the Prospectus or any further
amendment or supplement thereto, when such documents become
effective or are filed with the Commission, as the case may be,
will conform in all material respects to the requirements of the
Securities Act or the Exchange Act, as applicable, and the rules
and regulations of the Commission thereunder and will not contain
an untrue statement of a material fact or omit to state a material
fact required to be stated therein or necessary to make the
statements therein not misleading, and no such documents were filed
with the Commission since the Commission’s close of business
on the business day immediately prior to the date of this Agreement
and prior to the execution of this Agreement, except as set forth
on Schedule III to the Underwriting Agreement and except for such
other documents as were delivered to you prior to the Time of
Sale;
(e) The Prospectus and any
amendment or supplement thereto, as of the date thereof, do not and
will not contain any untrue statement of a material fact or omit to
state a material fact necessary to make the statements therein, in
the light of the circumstances under which they were made, not
misleading; provided , however , that this
representation and warranty shall not apply to statements or
omissions made in the Prospectus or any amendment or supplement
thereto in reliance upon and in conformity with information
furnished in writing to the Company by an Underwriter through the
Representatives expressly for use therein;
(f) No order preventing or
suspending the use of the Registration Statement has been issued by
the Commission;
(g) The Registration
Statement conforms, and the Prospectus and any further amendments
or supplements to the Registration Statement will conform, in all
material respects to the requirements of the Securities Act and the
Trust Indenture Act of 1939, as amended (the “Trust Indenture
Act”), and the rules and regulations of the Commission
thereunder and do not and will not, as of the applicable effective
date as to each part of the Registration Statement and as of the
applicable filing date as to the Prospectus and any amendment or
supplement thereto, contain any untrue statement of a material fact
or omit to state a material fact necessary to make the statements
therein, in the light of the circumstances under which they were
made, not misleading; provided , however , that this
representation and warranty shall not apply to any statements or
omissions made in reliance upon and in conformity with information
furnished in writing to the Company by an Underwriter of Securities
through the Representatives expressly for use therein;
(h) Since the respective
dates as of which information is given in the Pricing Prospectus,
there has not been any change in the capital stock (other than
increases in the stock
3
of the Company as the result
of the issuance of shares pursuant to any of the Company’s
stock option plans) or any material change in long-term debt of the
Company and its subsidiaries or any material adverse change, or any
development that the Company has a reasonable cause to believe
involves a prospective material adverse change, in the business,
financial position, shareholders’ equity or results of
operations of the Company and its subsidiaries taken as a whole,
otherwise than as set forth or contemplated in the Pricing
Prospectus;
(i) The Company has been duly
incorporated and is validly existing as a corporation in good
standing under the laws of the State of Delaware, with power and
authority (corporate and other) to own its properties and conduct
its business as described in the Pricing Prospectus, and has been
duly qualified as a foreign corporation for the transaction of
business and is in good standing in each jurisdiction in which the
conduct of its business or the ownership or leasing of its property
requires such qualification, except where failure to qualify would
not in the aggregate have a material adverse effect upon the
Company and its subsidiaries taken as a whole; and BNSF Railway
Company (hereinafter referred to as the “Significant
Subsidiary”) has been duly incorporated and is validly
existing as a corporation in good standing under the laws of its
jurisdiction of incorporation;
(j) The Company has an
authorized capitalization as set forth in the Pricing Prospectus,
and all of the issued shares of capital stock of the Company have
been duly and validly authorized and issued, are fully paid and
non-assessable; and all of the issued shares of capital stock of
the Significant Subsidiary have been duly and validly authorized
and issued, are fully paid and non-assessable and except as set
forth in the Pricing Prospectus are owned directly or indirectly by
the Company, free and clear of all liens, encumbrances, equities or
claims;
(k) The Securities have been
duly authorized and, when the Securities are issued and delivered
pursuant to this Agreement, will have been duly executed,
authenticated, issued and delivered and will constitute valid and
legally binding obligations of the Company entitled to the benefits
provided by the Indenture, which will be substantially in the form
filed as an exhibit to the Registration Statement; assuming the due
authorization and execution by the Trustee, the Indenture has been
duly authorized and duly qualified under the Trust Indenture Act
and, at the Time of Delivery for such Securities (as defined in
Section 4 hereof), the Indenture will constitute a valid and
legally binding instrument, enforceable in accordance with its
terms, subject, as to enforcement, to bankruptcy, insolvency,
reorganization and other laws of general applicability relating to
or affecting creditors’ rights and to general equity
principles; and the Indenture conforms, and the Securities will
conform, to the descriptions thereof contained in the Pricing
Prospectus and the Prospectus;
(l) The issue and sale of the
Securities and the compliance by the Company with all of the
provisions of the Securities, the execution and delivery of the
Indenture and this Agreement and the consummation of the
transactions herein and therein contemplated will not conflict with
or result in a breach or violation of any of the terms or
provisions of, or constitute a default under, any indenture,
mortgage, deed of trust, loan agreement or other agreement or
instrument to which the Company or any of its subsidiaries is a
party or by which the Company or any of its subsidiaries is bound
or to which any of the property or assets of the Company or any of
its subsidiaries is subject except for such conflicts, breaches,
violations or defaults that will not individually or in the
aggregate have a material adverse effect on the business,
financial
4
position, shareholders’
equity or results of operations of the Company and its subsidiaries
taken as a whole, nor will such action result in any violation of
the provisions of the Amended and Restated Certificate of
Incorporation or By-laws of the Company or any statute or any
order, rule or regulation of any court or governmental agency or
body having jurisdiction over the Company or any of its
subsidiaries or any of their properties except for such violations
(other than with respect to the Company’s Amended and
Restated Certificate of Incorporation or By-laws) that will not
individually or in the aggregate have a material adverse effect on
the business, financial position, shareholders’ equity or
results of operations of the Company and its subsidiaries taken as
a whole; and no consent, approval, authorization, order,
registration or qualification of or with any such court or
governmental agency or body is required for the issue and sale of
the Securities or the consummation by the Company of the
transactions contemplated by this Agreement or the Indenture,
except such as have been, or will have been prior to the Time of
Sale, obtained under the Securities Act and the Trust Indenture Act
and such consents, approvals, authorizations, registrations or
qualifications as may be required under state securities or Blue
Sky laws in connection with the purchase and distribution of the
Securities by the Underwriters;
(m) Other than as set forth
in the Pricing Prospectus, there are no legal or governmental
proceedings pending to which the Company or any of its subsidiaries
is a party or of which any property of the Company or any of its
subsidiaries is the subject which, in either case, the Company has
reasonable cause to believe will individually or in the aggregate
have a material adverse effect on the financial position,
shareholders’ equity or results of operations of the Company
and its subsidiaries taken as a whole; and, to the best of the
Company’s knowledge, no such proceedings are threatened or
contemplated by governmental authorities or threatened by
others;
(n) PricewaterhouseCoopers
LLP, who has certified certain financial statements of the Company
and its subsidiaries, and has attested to the Company’s
internal control over financial reporting and management’s
assessment thereof, is an independent registered public accounting
firm as required by the Securities Act and the rules and
regulations of the Commission thereunder;
(o) The Company maintains a
system of internal control over financial reporting (as such term
is defined in Rule 13a-15(f) under the Exchange Act) that complies
with the requirements of the Exchange Act and has been designed by
the Company’s principal executive officer and principal
financial officer, or persons under their supervision, to provide
reasonable assurance regarding the reliability of financial
reporting and the preparation of financial statements for external
purposes in accordance with generally accepted accounting
principles. The Company’s internal control over financial
reporting is effective and the Company is not aware of any material
weaknesses in its internal control over financial
reporting;
(p) The Company maintains
disclosure controls and procedures (as such term is defined in Rule
13a-15(e) under the Exchange Act) that comply with the requirements
of the Exchange Act; such disclosure controls and procedures have
been designed to ensure that material information relating to the
Company and its subsidiaries is made known to the Company’s
principal executive officer and principal financial officer by
others within those entities; and such disclosure controls and
procedures are effective; and
5
(q) The Company is not, and
after giving effect to the offering and sale of the Securities and
the application of the proceeds thereof, will not be an
“investment company”, or an entity
“controlled” by an investment company as such terms are
defined in the Investment Company Act of 1940, as amended (the
“Investment Company Act”).
3. Upon the execution of this
Agreement and authorization by the Representatives of the release
of the Securities, the several Underwriters propose to offer the
Securities for sale upon the terms and conditions set forth in the
Prospectus.
4. Securities to be purchased
by each Underwriter pursuant to this Agreement will be represented
by one or more definitive global Securities in book-entry form
which will be deposited by or on behalf of the Company with the
Depository Trust Company (“DTC”) or its designated
custodian. The Company will deliver the Securities to the
Representatives for the account of such Underwriter, against
payment by such Underwriter or on its behalf of the purchase price
therefor by wire transfer of such funds as may be specified in
Schedule II to the Underwriting Agreement, all at the place and
time and date specified in this Agreement or at such other place
and time and date as the Representatives and the Company may agree
upon in writing, such time and date being herein called the
“Time of Delivery”.
5. The Company agrees with
each of the Underwriters:
(a) To prepare the Prospectus
in a form approved by the Representatives, which approval shall not
be unreasonably withheld or delayed, and to file such Prospectus
pursuant to Rule 424(b) under the Securities Act not later than the
Commission’s close of business on the second business day
following the execution and delivery of this Agreement or, if
applicable, such earlier time as may be required by Rule 424(b); to
make no further amendment or any supplement to the Registration
Statement or Prospectus after the date of this Agreement and prior
to the Time of Delivery without giving you advance notice thereof
and an opportunity to comment thereon; to advise the
Representatives promptly of any such amendment or supplement after
such Time of Delivery and furnish the Representat
|